Maryland House Bill 1101 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Republican 5-0)
Status: Introduced on February 8 2019 - 25% progression, died in committee
Action: 2019-02-19 - Hearing 3/08 at 1:00 p.m.
Pending: House Health and Government Operations Committee
Text: Latest bill text (Introduced) [PDF]

Requiring the Maryland Department of Health to adopt certain regulations regarding the administration of mifepristone; requiring that mifepristone be provided by or under the supervision of a physician who meets certain qualifications and conditions; requiring each provider of mifepristone to make certain certifications and disclose certain information; establishing a certain penalty; requiring the Department to report to the General Assembly on or before December 1, 2019, and each December 1 thereafter; etc.

Health - Mifepristone - Administration

Del. Dan Cox [R]	Del. Joseph Boteler [R]	Del. Richard Impallaria [R]	Del. Charles Otto [R]
Del. Teresa Reilly [R]

Date	Chamber	Action
2019-02-19	House	Hearing 3/08 at 1:00 p.m.
2019-02-08	House	First Reading Health and Government Operations

Type	Source
Summary	https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB1101?ys=2019rs
Text	https://mgaleg.maryland.gov/2019RS/bills/hb/hb1101f.pdf
Supplement	https://mgaleg.maryland.gov/2019RS/fnotes/bil_0001/hb1101.pdf